Compare MYO & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYO | YI |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2M | 38.1M |
| IPO Year | 2017 | N/A |
| Metric | MYO | YI |
|---|---|---|
| Price | $1.01 | $3.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 830.5K | 13.5K |
| Earning Date | 11-10-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $41,643,203.00 | ★ $1,979,883,442.00 |
| Revenue This Year | $24.07 | N/A |
| Revenue Next Year | $17.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 65.00 | N/A |
| 52 Week Low | $0.71 | $3.19 |
| 52 Week High | $7.17 | $11.35 |
| Indicator | MYO | YI |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 40.27 |
| Support Level | $1.02 | $3.32 |
| Resistance Level | $1.13 | $3.94 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 59.57 | 44.59 |
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.